RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-5222
Malaria parasiteP. yoelii
Genotype
MutatedGene model (rodent): PBANKA_0403200; Gene model (P.falciparum): PF3D7_0304600; Gene product: circumsporozoite (CS) protein (CSP)
Details mutation: Pexel I and II domains of CSP were mutated into ANANA and ALAGA
Transgene
Transgene not Plasmodium: RFP (RedStar)
Promoter: Gene model: PBANKA_1133300; Gene model (P.falciparum): PF3D7_1357100; Gene product: elongation factor 1-alpha (eef1a)
3'UTR: Gene model: PBANKA_0719300; Gene product: bifunctional dihydrofolate reductase-thymidylate synthase, putative (dhfr/ts)
Replacement locus: Gene model: Not available; Gene product: Not available (small subunit ribosomal rna gene (c/d-type unit))
Phenotype Oocyst; Sporozoite;
Last modified: 22 July 2022, 16:24
  *RMgm-5222
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene mutation, Introduction of a transgene
Reference (PubMed-PMID number) Reference 1 (PMID number) : 35680915
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. yoelii
Parent strain/lineP. y. yoelii 265BY
Name parent line/clone RMgm-5221
Other information parent lineThe mutant (RMgm-5221) expresses RFP (RedStar) under control of the constitutive eef1a promoter. The RFP expression cassette has been introduced by single cross-over integration into the small subunit ribosomal rna gene (c/d-type unit)
The mutant parasite was generated by
Name PI/ResearcherZhu F, Xu W
Name Group/DepartmentDepartment of Pathogenic Biology, Army Medical University
Name InstituteThird Military Medical University
CityChongqing
CountryChina
Name of the mutant parasite
RMgm numberRMgm-5222
Principal nameCSP(mut)
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNot tested
OocystThe number and size of CSPmut oocysts were comparable to those of CSP wild-type parasites. Although a few sporozoites were observed in the hemolymph, none were found in the salivary glands of mosquitoes. Melanization of oocyst from day 7 with different amounts of black dots deposited inside the oocyst capsule on day 12. Under electronic microscopy, some mature CSPmut oocysts generated thousands of sporozoites with normal morphology, but many sporozoites were found to be vacuolated and partially melanized at day 11. The percentage of the melanized CSPmut oocysts increased from an average of 28.2% on day 9, to 49.3% on day 12, and 73.2% on day 15.
SporozoiteThe number and size of CSPmut oocysts were comparable to those of CSP wild-type parasites. Although a few sporozoites were observed in the hemolymph, none were found in the salivary glands of mosquitoes. Melanization of oocyst from day 7 with different amounts of black dots deposited inside the oocyst capsule on day 12. Under electronic microscopy, some mature CSPmut oocysts generated thousands of sporozoites with normal morphology, but many sporozoites were found to be vacuolated and partially melanized at day 11. The percentage of the melanized CSPmut oocysts increased from an average of 28.2% on day 9, to 49.3% on day 12, and 73.2% on day 15.
Liver stageNot tested
Additional remarks phenotype

Mutant/mutation
The mutant expresses a mutated form of CSP where Pexel I and II domains of CSP were mutated into ANANA and ALAGA (The first, third, and fifth amino acids of pexel I (RNLNE) and pexel II (RLLGD) in wild-type CSP presented mutations from R, L, E and R, L, D to A) 
In addition, the mutant expresses RFP (RedStar) under control of the constitutive eef1a promoter.

Protein (function)
The CS protein is the major protein on the surface of sporozoites and is critical for development of sporozoites within the oocysts and is involved in motility and invasion of both the salivary gland of the mosquito and the liver cells. The protein is also found on the oocyst plasma membrane and on the inner surface of the oocyst capsule. Specific motifs in CS are involved in sporozoite binding to mosquito salivary glands and in sporozoite attachment to heparan sulfate proteoglycans in the liver of the mammalian host. During substrate-dependent locomotion of sporozoites, CS is secreted at the sporozoite anterior pole, translocated along the sporozoite axis and released on the substrate at the sporozoite posterior pole. Following sporozoite invasion of hepatocytes, the CS is released in the host cell cytoplasm.

Phenotype
The number and size of CSPmut oocysts were comparable to those of CSP wild-type parasites. Although a few sporozoites were observed in the hemolymph, none were found in the salivary glands of mosquitoes. Melanization of oocyst from day 7 with different amounts of black dots deposited inside the oocyst capsule on day 12. Under electronic microscopy, some mature CSPmut oocysts generated thousands of sporozoites with normal morphology, but many sporozoites were found to be vacuolated and partially melanized at day 11. The percentage of the melanized CSPmut oocysts increased from an average of 28.2% on day 9, to 49.3% on day 12, and 73.2% on day 15.

Additional information
TEP1 was only observed to bind to the surface of CSPmut oocysts and co-localized with CSP protein inside the mutant oocysts, but not for CSPwt oocysts at day 7 PI. When TEP1 was silenced, however, no oocysts were found to be melanized in CSPmut parasite-infected mosquitoes on day 12 PI, and an increased number of CSPmut sporozoites appeared in the hemolymph. Both the motility and infectivity of CSPmut hemolymph sporozoites were comparable to those of the CSPwt hemolymph sporozoites in vitro, indicating no biological defect in mutant parasites.


Other mutants


  Mutated: Mutant parasite with a mutated gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_0403200
Gene Model P. falciparum ortholog PF3D7_0304600
Gene productcircumsporozoite (CS) protein
Gene product: Alternative nameCSP
Details of the genetic modification
Short description of the mutationPexel I and II domains of CSP were mutated into ANANA and ALAGA
Inducable system usedNo
Short description of the conditional mutagenesisNot available
Additional remarks inducable system
Type of plasmid/constructCRISPR/Cas9 construct: integration through double strand break repair
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr/yfcu
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationUsing CRISPR-Cas9 technology, P. yoelii 265BY parasites were generated by replacing the P. yoelii 265BY WT CSP sequence with a mutated CSP pexel I/II domain sequence (the sequences of pexel I and pexel II were mutated into ANANA and ALAGA, respectively). Briefly, a single guide RNA (5'-GATTCTCTACTTCCAGGATA-3') specifically targeting the P. yoelii 265BY CSP gene (GenBank Gene ID: DQ012939.1) was inserted downstream of the Plasmodium U6 promoter in the pYC plasmid (donated by Dr. Jing Yuan, Xia’men University, China). The homologous recombinant fragment, containing a 5' untranslated region (551 bp) and a fragment encoding the mutated CSP pexel I/II domain (1284 bp), was constructed by overlapping PCR and then inserted into the multiple cloning sites of the pYC plasmid. The resulting pYC-CSPmut recombinant plasmid was amplified, purified using the E.Z.N.A® Endo-Free Plasmid Midi Kit (Omega Bio-Tek, GA, USA), and electroporated into synchronic schizont cultures
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene nameRFP (RedStar)
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid single cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitetgdhfr
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationP. y. yoelii 265BY-RFP was constructed by inserting RFP into the ssurRNA gene of P. y. yoelii 265BY.
In brief, PL1102 (a gift from MR4) was electroporated into cultured shizonts of P. y. yoelii 265BY and injected into a mouse.
One day later, the mice were treated with pyrimethamine in their drinking water for six days and parasites were collected and cloned.
Additional remarks selection procedure
Other details transgene
Promoter
Gene Model of Parasite PBANKA_1133300
Gene Model P. falciparum ortholog PF3D7_1357100
Gene productelongation factor 1-alpha
Gene product: Alternative nameeef1a
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite PBANKA_0719300
Gene productbifunctional dihydrofolate reductase-thymidylate synthase, putative
Gene product: Alternative namedhfr/ts
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionReplacement locus
Gene Model of Parasite Not available
Gene productNot available
Gene product: Alternative namesmall subunit ribosomal rna gene (c/d-type unit)
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4